The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Gene Review

Cyp2c12  -  cytochrome P450, family 2, subfamily c,...

Rattus norvegicus

Synonyms: CYPIIC12, Cyp2c-12, Cyp2c40, Cytochrome P450 15-beta, Cytochrome P450 2C12, female-specific, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Cyp2c40

 

High impact information on Cyp2c40

  • Recently, three types of urea transporters have been cloned, UT1 and UT2 from rat and rabbit kidney and HUT11 from human bone marrow [2].
  • We report here the cloning of a novel urea transporter, designated UT1, from the rat inner medulla which is functionally and structurally distinct from the previously reported kidney urea transporter UT2 [3].
  • Taken together, our data show that UT1 corresponds to the previously characterized vasopressin-regulated urea transporter in the apical membrane of the terminal IMCD which plays a critical role in renal water conservation [3].
  • Studies of the rat genomic DNA further indicated that UT1 and UT2 are derived from a single gene by alternative splicing [3].
  • UT1 expressed in Xenopus oocytes mediated passive transport of urea that was inhibited by phloretin and urea analogs but, in contrast to UT2, was strongly stimulated by cAMP agonists [3].
 

Biological context of Cyp2c40

 

Anatomical context of Cyp2c40

  • Specific antibodies to isozyme 15 beta were used with a Western blot technique to demonstrate the virtual absence of the protein in male microsomes [7].
  • Western blot analyses revealed clear differences in the expression of proteins immunologically related to cytochrome P-450 PB-1, and glutathione transferases B and X in parenchymal cells compared with the corresponding Kupffer and endothelial cells [8].
  • In contrast, little or no phosphorylation of P-450 forms reactive with antibodies to P-450 PB-1 (gene IIC6), P-450 2c (gene IIC11), or P-450 PB-2a (gene IIIA1) was detected in the isolated hepatocytes under these incubation conditions [9].
  • In vitro cytosol binding assays have shown the properties of binding of a novel steroid, ZK91587 (15 beta, 16 beta-methylene-mexrenone) in the brain of rats [10].
  • Immunoblot analysis of rat liver microsomes with anti-P-450 PCN indicated that the amount of P-450 PCN increased 5- to 7-fold by the treatment with M79193, but no increase was observed in P-450 PB-1 (P450IIB1) or P-450 MC-1 (P-450IA1) [11].
 

Associations of Cyp2c40 with chemical compounds

  • Therefore, it is concluded that P-450 isozymes 15 beta, 16 alpha, f, and PB-1 represent a subfamily within the phenobarbital related cytochrome P-450 gene family [12].
  • Our studies reveal the role of vasopressin in long-term regulation of UT1 and UT2 expression during water restriction [1].
  • The hydrophobicity values of the NH2-terminal sequences of P450 UT-1 and P450 UT-8 were lower than that of other forms [13].
  • Lauric acid was also hydroxylated by P450 UT-1, UT-2, PB-1, PB-2, MC-1, IF-3 (P-450a) and DM, at the (omega - 1)-position only [14].
  • In a reconstituted system with purified cytochromes P-450, P450 UT-1, UT-2 (P-450h), MC-1 (P-450d) and MC-5 (P-450c) effectively hydroxylated arachidonic acid at both the omega- and (omega-1)-position [14].
 

Regulatory relationships of Cyp2c40

  • In situ hybridization further demonstrated that the UT2 signal is upregulated and spread along the descending thin limbs of loops of Henle and that UT1 signal is downregulated in the inner medullary collecting ducts in vasopressin-treated rats, with a greater response for dDAVP compared with the AVP-treated group [1].
  • We previously demonstrated that renin release by kidney slices may be increased by beta-adrenergic agonists, and the present communication contains our results on the effects of 15 beta-blocking agents and angiotensin II on isoproterenol-stimulated renin release [15].
 

Other interactions of Cyp2c40

  • Furthermore, P-450 15 beta is 47% similar to the major phenobarbital-inducible cytochrome P-450 in rat liver, P-450 b, while its structural similarity to P-450 c, P-450 pregnenolone-16a-carbonitrile, and P-450 lauric acid omega-hydroxylase is less than 30% [4].
  • The NH2-terminal sequences of six forms of cytochrome P-450 (designated P450 UT-1, UT-2, UT-4, UT-5, UT-7 and UT-8) indicate that these cytochrome P-450 isozymes are of different molecular species [13].
  • Slight changes in cytochromes P-450 UT-F, P-450 UT-I and P-450 PB-C were also observed under these conditions, but the biological significance is not known [16].
  • Also, the N-demethylation activities of P-450s UT-1, PB-1, PB-2, and MC-1 were increased by cytochrome b5 [5].
  • We believe that P450 UT-1, P450 UT-7 and P450 UT-8 are as yet unrecognized forms of cytochrome P-450 [13].
 

Analytical, diagnostic and therapeutic context of Cyp2c40

  • Immunocytochemistry studies revealed that the UT1 and UT2 proteins are also modified in the same pattern as the transcript changes [1].
  • Northern analysis showed that water restriction alone had no effect on the level of UT2 mRNA in vehicle-treated Brattleboro rats but UT2 mRNA markedly increased and UT1 mRNA modestly decreased after treatment with dDAVP [1].

References

  1. Long-term regulation of urea transporter expression by vasopressin in Brattleboro rats. Shayakul, C., Smith, C.P., Mackenzie, H.S., Lee, W.S., Brown, D., Hediger, M.A. Am. J. Physiol. Renal Physiol. (2000) [Pubmed]
  2. Cloning and characterization of the urea transporter UT3: localization in rat kidney and testis. Tsukaguchi, H., Shayakul, C., Berger, U.V., Tokui, T., Brown, D., Hediger, M.A. J. Clin. Invest. (1997) [Pubmed]
  3. Molecular cloning and characterization of the vasopressin-regulated urea transporter of rat kidney collecting ducts. Shayakul, C., Steel, A., Hediger, M.A. J. Clin. Invest. (1996) [Pubmed]
  4. cDNA cloning, sequence, and regulation of a major female-specific and growth hormone-inducible rat liver cytochrome P-450 active in 15 beta-hydroxylation of steroid sulfates. Zaphiropoulos, P.G., Mode, A., Ström, A., Möller, C., Fernandez, C., Gustafsson, J.A. Proc. Natl. Acad. Sci. U.S.A. (1988) [Pubmed]
  5. Aminopyrine metabolism by multiple forms of cytochrome P-450 from rat liver microsomes: simultaneous quantitation of four aminopyrine metabolites by high-performance liquid chromatography. Imaoka, S., Inoue, K., Funae, Y. Arch. Biochem. Biophys. (1988) [Pubmed]
  6. Segmental localization of urea transporter mRNAs in rat kidney. Shayakul, C., Knepper, M.A., Smith, C.P., DiGiovanni, S.R., Hediger, M.A. Am. J. Physiol. (1997) [Pubmed]
  7. Purification, characterization, and pituitary regulation of the sex-specific cytochrome P-450 15 beta-hydroxylase from liver microsomes of untreated female rats. MacGeoch, C., Morgan, E.T., Halpert, J., Gustafsson, J.A. J. Biol. Chem. (1984) [Pubmed]
  8. Xenobiotic metabolizing enzymes are not restricted to parenchymal cells in rat liver. Steinberg, P., Lafranconi, W.M., Wolf, C.R., Waxman, D.J., Oesch, F., Friedberg, T. Mol. Pharmacol. (1987) [Pubmed]
  9. Posttranslational modification of hepatic cytochrome P-450. Phosphorylation of phenobarbital-inducible P-450 forms PB-4 (IIB1) and PB-5 (IIB2) in isolated rat hepatocytes and in vivo. Koch, J.A., Waxman, D.J. Biochemistry (1989) [Pubmed]
  10. ZK91587: a novel synthetic antimineralocorticoid displays high affinity for corticosterone (type I) receptors in the rat hippocampus. Sutanto, W., de Kloet, E.R. Life Sci. (1988) [Pubmed]
  11. Induction and immunohistochemical localization of cytochrome P-450 PCN by non-steroidal compound, in rat liver microsomes. Sagami, F., Tsukidate, K., Fukuda, T., Nakanowatari, J., Horie, T., Igarashi, T., Kitada, M., Kanakubo, Y. Res. Commun. Chem. Pathol. Pharmacol. (1990) [Pubmed]
  12. Sequence and regulation of two growth-hormone-controlled, sex-specific isozymes of cytochrome P-450 in rat liver, P-450(15)beta and P-450(16)alpha. Zaphiropoulos, P.G., Mode, A., Ström, A., Husman, B., Andersson, G., Gustafsson, J.A. Acta Med. Scand. Suppl. (1988) [Pubmed]
  13. Purification and characterization of liver microsomal cytochrome P-450 from untreated male rats. Funae, Y., Imaoka, S. Biochim. Biophys. Acta (1987) [Pubmed]
  14. Omega- and (omega-1)-hydroxylation of arachidonic acid, lauric acid and prostaglandin A1 by multiple forms of cytochrome P-450 purified from rat hepatic microsomes. Tanaka, S., Imaoka, S., Kusunose, E., Kusunose, M., Maekawa, M., Funae, Y. Biochim. Biophys. Acta (1990) [Pubmed]
  15. Effect of beta-blocking agents and angiotensin II on isoproterenol-stimulated renin release from rat kidney slices. Capponi, A.M., Gourjon, M., Vallotton, M.B. Circ. Res. (1977) [Pubmed]
  16. Similarities and differences in the regulation of hepatic cytochrome P-450 enzymes by diabetes and fasting in male rats. Ma, Q., Dannan, G.A., Guengerich, F.P., Yang, C.S. Biochem. Pharmacol. (1989) [Pubmed]
 
WikiGenes - Universities